Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Protein Networks02:26

Protein Networks

4.1K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.1K
Protein-protein Interfaces02:04

Protein-protein Interfaces

13.8K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
13.8K
Drug Discovery: Overview01:26

Drug Discovery: Overview

8.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.9K
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance01:07

Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance

90
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
90
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

403
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
403
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

132
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
132

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Two-year-supervised resistance training prevented diabetes incidence in people with prediabetes: A randomised control trial.

Diabetes/metabolism research and reviews·2019
Same author

Preliminary evaluation of a predictive controller for a rotary blood pump based on pulmonary oxygen gas exchange.

Proceedings of the Institution of Mechanical Engineers. Part H, Journal of engineering in medicine·2019
Same author

A Destructive New Disease of Citrus in China Caused by Cryptosporiopsis citricarpa sp. nov.

Plant disease·2019
Same author

Effects of membrane reference state on shape memory of a red blood cell.

Computer methods in biomechanics and biomedical engineering·2019
Same author

Ultrafast Photovoltaic-Type Deep Ultraviolet Photodetectors Using Hybrid Zero-/Two-Dimensional Heterojunctions.

ACS applied materials & interfaces·2019
Same author

Phenolic profile and antioxidant properties of sand rice (Agriophyllum squarrosum) as affected by cooking and in vitro digestion.

Journal of the science of food and agriculture·2019

Related Experiment Video

Updated: Sep 21, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.8K

A heterogeneous network-based method with attentive meta-path extraction for predicting drug-target interactions.

Hongzhun Wang1, Feng Huang1, Zhankun Xiong1

  • 1College of Informatics, Huazhong Agricultural University, Wuhan, 430070, Wuhan, China.

Briefings in Bioinformatics
|May 31, 2022
PubMed
Summary

This study introduces HampDTI, a new computational method for predicting drug-target interactions (DTIs). HampDTI automatically learns important pathways, improving DTI prediction accuracy and flexibility in drug discovery.

Keywords:
drug–target interactiongraph neural networksheterogeneous graphmeta-path

More Related Videos

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.2K
Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
13:18

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

1.4K

Related Experiment Videos

Last Updated: Sep 21, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.8K
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.2K
Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
13:18

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

1.4K

Area of Science:

  • Computational biology
  • Bioinformatics
  • Drug discovery

Background:

  • Predicting drug-target interactions (DTIs) is vital for drug discovery and repositioning.
  • Heterogeneous networks (HNs) capture biological knowledge using meta-paths, but manual customization limits scalability.
  • Existing methods rely on domain expertise for meta-path selection, hindering flexibility and performance.

Purpose of the Study:

  • To develop a novel HN-based method for DTI prediction that automatically extracts meta-paths.
  • To overcome the limitations of manual meta-path customization in existing DTI prediction models.
  • To enhance the scalability and predictive performance of DTI prediction through automated meta-path learning.

Main Methods:

  • Proposed HampDTI, a method utilizing an attention mechanism for automatic meta-path extraction from HNs.
  • Constructed meta-path graphs by scoring multi-hop connections with attention weights for trainable graph structures.
  • Employed a multi-channel mechanism to generate diverse meta-path graphs and a graph neural network for multi-channel embeddings.

Main Results:

  • HampDTI demonstrated superior performance in DTI prediction compared to baseline methods on benchmark datasets.
  • The model effectively identified and learned the importance of various meta-paths.
  • The automated meta-path extraction mechanism proved crucial for improved predictive accuracy.

Conclusions:

  • HampDTI offers a flexible and scalable approach to DTI prediction by automating meta-path extraction.
  • The attention-based meta-path learning significantly enhances prediction accuracy.
  • This method holds promise for advancing computational drug discovery and repositioning efforts.